Cochrane Evidence Synthesis and Methods ►

Pharmacological treatments for vaccine-induced immune thrombocytopenia and thrombosis (VITT) after COVID-19 vaccination

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of pharmacological interventions for vaccine-induced immune thrombocytopenia and thrombosis in people who received COVID-19 vaccination.

This is a protocol.

Health topics:

Heart & circulation > Thrombophilia & other causes of thrombosis

Published:

29 February 2024

Authors:

Magalhaes JV, Flumignan RLG, Civile VT, Flumignan CDQ, Cristino MAB, Reicher ME, Nakano LCU

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Magalhaes JV, Flumignan RLG, Civile VT, Flumignan CDQ, Cristino MAB, Reicher ME, Nakano LCU. Pharmacological treatments for vaccine-induced immune thrombocytopenia and thrombosis (VITT) after COVID-19 vaccination (Protocol). Cochrane Database of Systematic Reviews 2024, Issue 2. Art. No.: CD015369. DOI: 10.1002/14651858.CD015369.